Výsledky vyhledávání

Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial

Autor: Viscoli, C. M., Brass, L. M., Carolei, Antonio, Conwit, R., Ford, G. A., Furie, K. L., Gorman, M., Guarino, P. D., Inzucchi, S. E., Lovejoy, A. M., Parsons, M. W., Peduzzi, P. N., Ringleb, P. A., Schwartz, G. G., Spence, J. D., Tanne, D., Young, L. H., Kernan, W. N., IRIS Trial investigators

Publikováno v: Department of Medicine Publications

Background Recurrent vascular events remain a major source of morbidity and mortality after stroke or transient ischemic attack (TIA). The IRIS Trial is evaluating an approach to secondary prevention based on the established association between insul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf8e35d473d0ff1133a5901d30011867
https://pubmed.ncbi.nlm.nih.gov/25458644

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

Autor: Diener, H. C., Bogousslavsky, J, Brass, L. M., Cimminiello, C, Csiba, L, Kaste, M, Leys, D, MATIAS GUIU, J, Rupprecht, H. J., ON BEALF OF THE MATCH INVESTIGATORS, Carolei, Antonio

Publikováno v: Lancet (UK), 364, 331-337. Elsevier Ltd.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ea6ec8cd3e0e2732597cdab8bfc38184
https://pure.eur.nl/en/publications/2bd2b72d-ecfa-4cbd-a082-08af9052ebc1

Zobrazit plný text záznamu

Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH) study design and baseline data

Autor: Diener, H. C., Bogousslavsky, J, Brass, L. M., Cimminiello, C, Csiba, L, Kaste, M, Leys, D, MATIAS GUIU, J, ON BEHALF OF THE MATCH INVESTIGATORS, RUPPRECHT H. S., Carolei, Antonio

Background: The CAPRIE study showed the superiority of clopidogrel over acetylsalicylic acid (ASA) for reducing the combined risk of major atherothrombotic events in patients with recent myocardial infarction (MI), recent ischaemic stroke (IS) or est

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::303d3238535a0178278f595a3d15c432
http://hdl.handle.net/11697/1530

Zobrazit plný text záznamu